1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Internal Neuromodulation Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Spinal Cord Stimulation 1.2.3 Deep Brain Stimulation 1.2.4 Vagus Nerve Stimulation 1.2.5 Sacral Nerve Stimulation 1.2.6 Gastric Electrical Stimulation 1.2.7 Others 1.3 Market by Application 1.3.1 Global Internal Neuromodulation Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Disease Therapy 1.3.3 Research and Development 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Internal Neuromodulation Market Perspective (2017-2028) 2.2 Internal Neuromodulation Growth Trends by Region 2.2.1 Internal Neuromodulation Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Internal Neuromodulation Historic Market Size by Region (2017-2022) 2.2.3 Internal Neuromodulation Forecasted Market Size by Region (2023-2028) 2.3 Internal Neuromodulation Market Dynamics 2.3.1 Internal Neuromodulation Industry Trends 2.3.2 Internal Neuromodulation Market Drivers 2.3.3 Internal Neuromodulation Market Challenges 2.3.4 Internal Neuromodulation Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Internal Neuromodulation Players by Revenue 3.1.1 Global Top Internal Neuromodulation Players by Revenue (2017-2022) 3.1.2 Global Internal Neuromodulation Revenue Market Share by Players (2017-2022) 3.2 Global Internal Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Internal Neuromodulation Revenue 3.4 Global Internal Neuromodulation Market Concentration Ratio 3.4.1 Global Internal Neuromodulation Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Internal Neuromodulation Revenue in 2021 3.5 Internal Neuromodulation Key Players Head office and Area Served 3.6 Key Players Internal Neuromodulation Product Solution and Service 3.7 Date of Enter into Internal Neuromodulation Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Internal Neuromodulation Breakdown Data by Type 4.1 Global Internal Neuromodulation Historic Market Size by Type (2017-2022) 4.2 Global Internal Neuromodulation Forecasted Market Size by Type (2023-2028) 5 Internal Neuromodulation Breakdown Data by Application 5.1 Global Internal Neuromodulation Historic Market Size by Application (2017-2022) 5.2 Global Internal Neuromodulation Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Internal Neuromodulation Market Size (2017-2028) 6.2 North America Internal Neuromodulation Market Size by Country (2017-2022) 6.3 North America Internal Neuromodulation Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Internal Neuromodulation Market Size (2017-2028) 7.2 Europe Internal Neuromodulation Market Size by Country (2017-2022) 7.3 Europe Internal Neuromodulation Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Internal Neuromodulation Market Size (2017-2028) 8.2 Asia-Pacific Internal Neuromodulation Market Size by Country (2017-2022) 8.3 Asia-Pacific Internal Neuromodulation Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Internal Neuromodulation Market Size (2017-2028) 9.2 Latin America Internal Neuromodulation Market Size by Country (2017-2022) 9.3 Latin America Internal Neuromodulation Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Internal Neuromodulation Market Size (2017-2028) 10.2 Middle East & Africa Internal Neuromodulation Market Size by Country (2017-2022) 10.3 Middle East & Africa Internal Neuromodulation Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Medtronic 11.1.1 Medtronic Company Detail 11.1.2 Medtronic Business Overview 11.1.3 Medtronic Internal Neuromodulation Introduction 11.1.4 Medtronic Revenue in Internal Neuromodulation Business (2017-2022) 11.1.5 Medtronic Recent Development 11.2 Boston Scientific Corporation 11.2.1 Boston Scientific Corporation Company Detail 11.2.2 Boston Scientific Corporation Business Overview 11.2.3 Boston Scientific Corporation Internal Neuromodulation Introduction 11.2.4 Boston Scientific Corporation Revenue in Internal Neuromodulation Business (2017-2022) 11.2.5 Boston Scientific Corporation Recent Development 11.3 Abbott 11.3.1 Abbott Company Detail 11.3.2 Abbott Business Overview 11.3.3 Abbott Internal Neuromodulation Introduction 11.3.4 Abbott Revenue in Internal Neuromodulation Business (2017-2022) 11.3.5 Abbott Recent Development 11.4 LivaNova 11.4.1 LivaNova Company Detail 11.4.2 LivaNova Business Overview 11.4.3 LivaNova Internal Neuromodulation Introduction 11.4.4 LivaNova Revenue in Internal Neuromodulation Business (2017-2022) 11.4.5 LivaNova Recent Development 11.5 Synapse Biomedical 11.5.1 Synapse Biomedical Company Detail 11.5.2 Synapse Biomedical Business Overview 11.5.3 Synapse Biomedical Internal Neuromodulation Introduction 11.5.4 Synapse Biomedical Revenue in Internal Neuromodulation Business (2017-2022) 11.5.5 Synapse Biomedical Recent Development 11.6 Nevro Corporation 11.6.1 Nevro Corporation Company Detail 11.6.2 Nevro Corporation Business Overview 11.6.3 Nevro Corporation Internal Neuromodulation Introduction 11.6.4 Nevro Corporation Revenue in Internal Neuromodulation Business (2017-2022) 11.6.5 Nevro Corporation Recent Development 11.7 NeuroSigma 11.7.1 NeuroSigma Company Detail 11.7.2 NeuroSigma Business Overview 11.7.3 NeuroSigma Internal Neuromodulation Introduction 11.7.4 NeuroSigma Revenue in Internal Neuromodulation Business (2017-2022) 11.7.5 NeuroSigma Recent Development 11.8 NeuroPace 11.8.1 NeuroPace Company Detail 11.8.2 NeuroPace Business Overview 11.8.3 NeuroPace Internal Neuromodulation Introduction 11.8.4 NeuroPace Revenue in Internal Neuromodulation Business (2017-2022) 11.8.5 NeuroPace Recent Development 11.9 Neuronetics 11.9.1 Neuronetics Company Detail 11.9.2 Neuronetics Business Overview 11.9.3 Neuronetics Internal Neuromodulation Introduction 11.9.4 Neuronetics Revenue in Internal Neuromodulation Business (2017-2022) 11.9.5 Neuronetics Recent Development 11.10 BioControl Medical 11.10.1 BioControl Medical Company Detail 11.10.2 BioControl Medical Business Overview 11.10.3 BioControl Medical Internal Neuromodulation Introduction 11.10.4 BioControl Medical Revenue in Internal Neuromodulation Business (2017-2022) 11.10.5 BioControl Medical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Internal Neuromodulation Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Spinal Cord Stimulation Table 3. Key Players of Deep Brain Stimulation Table 4. Key Players of Vagus Nerve Stimulation Table 5. Key Players of Sacral Nerve Stimulation Table 6. Key Players of Gastric Electrical Stimulation Table 7. Key Players of Others Table 8. Global Internal Neuromodulation Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Internal Neuromodulation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global Internal Neuromodulation Market Size by Region (2017-2022) & (US$ Million) Table 11. Global Internal Neuromodulation Market Share by Region (2017-2022) Table 12. Global Internal Neuromodulation Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global Internal Neuromodulation Market Share by Region (2023-2028) Table 14. Internal Neuromodulation Market Trends Table 15. Internal Neuromodulation Market Drivers Table 16. Internal Neuromodulation Market Challenges Table 17. Internal Neuromodulation Market Restraints Table 18. Global Internal Neuromodulation Revenue by Players (2017-2022) & (US$ Million) Table 19. Global Internal Neuromodulation Market Share by Players (2017-2022) Table 20. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2021) Table 21. Ranking of Global Top Internal Neuromodulation Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by Internal Neuromodulation Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Internal Neuromodulation Product Solution and Service Table 25. Date of Enter into Internal Neuromodulation Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Internal Neuromodulation Market Size by Type (2017-2022) & (US$ Million) Table 28. Global Internal Neuromodulation Revenue Market Share by Type (2017-2022) Table 29. Global Internal Neuromodulation Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global Internal Neuromodulation Revenue Market Share by Type (2023-2028) Table 31. Global Internal Neuromodulation Market Size by Application (2017-2022) & (US$ Million) Table 32. Global Internal Neuromodulation Revenue Market Share by Application (2017-2022) Table 33. Global Internal Neuromodulation Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global Internal Neuromodulation Revenue Market Share by Application (2023-2028) Table 35. North America Internal Neuromodulation Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Internal Neuromodulation Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Internal Neuromodulation Market Size by Country (2017-2022) & (US$ Million) Table 38. Europe Internal Neuromodulation Market Size by Country (2023-2028) & (US$ Million) Table 39. Asia-Pacific Internal Neuromodulation Market Size by Region (2017-2022) & (US$ Million) Table 40. Asia-Pacific Internal Neuromodulation Market Size by Region (2023-2028) & (US$ Million) Table 41. Latin America Internal Neuromodulation Market Size by Country (2017-2022) & (US$ Million) Table 42. Latin America Internal Neuromodulation Market Size by Country (2023-2028) & (US$ Million) Table 43. Middle East & Africa Internal Neuromodulation Market Size by Country (2017-2022) & (US$ Million) Table 44. Middle East & Africa Internal Neuromodulation Market Size by Country (2023-2028) & (US$ Million) Table 45. Medtronic Company Detail Table 46. Medtronic Business Overview Table 47. Medtronic Internal Neuromodulation Product Table 48. Medtronic Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 49. Medtronic Recent Development Table 50. Boston Scientific Corporation Company Detail Table 51. Boston Scientific Corporation Business Overview Table 52. Boston Scientific Corporation Internal Neuromodulation Product Table 53. Boston Scientific Corporation Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 54. Boston Scientific Corporation Recent Development Table 55. Abbott Company Detail Table 56. Abbott Business Overview Table 57. Abbott Internal Neuromodulation Product Table 58. Abbott Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 59. Abbott Recent Development Table 60. LivaNova Company Detail Table 61. LivaNova Business Overview Table 62. LivaNova Internal Neuromodulation Product Table 63. LivaNova Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 64. LivaNova Recent Development Table 65. Synapse Biomedical Company Detail Table 66. Synapse Biomedical Business Overview Table 67. Synapse Biomedical Internal Neuromodulation Product Table 68. Synapse Biomedical Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 69. Synapse Biomedical Recent Development Table 70. Nevro Corporation Company Detail Table 71. Nevro Corporation Business Overview Table 72. Nevro Corporation Internal Neuromodulation Product Table 73. Nevro Corporation Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 74. Nevro Corporation Recent Development Table 75. NeuroSigma Company Detail Table 76. NeuroSigma Business Overview Table 77. NeuroSigma Internal Neuromodulation Product Table 78. NeuroSigma Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 79. NeuroSigma Recent Development Table 80. NeuroPace Company Detail Table 81. NeuroPace Business Overview Table 82. NeuroPace Internal Neuromodulation Product Table 83. NeuroPace Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 84. NeuroPace Recent Development Table 85. Neuronetics Company Detail Table 86. Neuronetics Business Overview Table 87. Neuronetics Internal Neuromodulation Product Table 88. Neuronetics Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 89. Neuronetics Recent Development Table 90. BioControl Medical Company Detail Table 91. BioControl Medical Business Overview Table 92. BioControl Medical Internal Neuromodulation Product Table 93. BioControl Medical Revenue in Internal Neuromodulation Business (2017-2022) & (US$ Million) Table 94. BioControl Medical Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Global Internal Neuromodulation Market Share by Type: 2021 VS 2028 Figure 2. Spinal Cord Stimulation Features Figure 3. Deep Brain Stimulation Features Figure 4. Vagus Nerve Stimulation Features Figure 5. Sacral Nerve Stimulation Features Figure 6. Gastric Electrical Stimulation Features Figure 7. Others Features Figure 8. Global Internal Neuromodulation Market Share by Application in 2021 & 2028 Figure 9. Disease Therapy Case Studies Figure 10. Research and Development Case Studies Figure 11. Internal Neuromodulation Report Years Considered Figure 12. Global Internal Neuromodulation Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Internal Neuromodulation Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Internal Neuromodulation Market Share by Region: 2021 VS 2028 Figure 15. Global Internal Neuromodulation Market Share by Players in 2021 Figure 16. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Internal Neuromodulation Revenue in 2021 Figure 18. North America Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Internal Neuromodulation Market Share by Country (2017-2028) Figure 20. United States Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Internal Neuromodulation Market Share by Country (2017-2028) Figure 24. Germany Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Internal Neuromodulation Market Share by Region (2017-2028) Figure 32. China Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Internal Neuromodulation Market Share by Country (2017-2028) Figure 40. Mexico Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Internal Neuromodulation Market Share by Country (2017-2028) Figure 44. Turkey Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Internal Neuromodulation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Medtronic Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 47. Boston Scientific Corporation Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 48. Abbott Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 49. LivaNova Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 50. Synapse Biomedical Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 51. Nevro Corporation Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 52. NeuroSigma Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 53. NeuroPace Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 54. Neuronetics Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 55. BioControl Medical Revenue Growth Rate in Internal Neuromodulation Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Medtronic Boston Scientific Corporation Abbott LivaNova Synapse Biomedical Nevro Corporation NeuroSigma NeuroPace Neuronetics BioControl Medical